Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2023 Jun 22. Online ahead of print. doi: 10.1016/j.pedneo.2023.05.002

Pathophysiological and clinical point of view on Kawasaki disease and MIS-C

Lenka Vaňková a,b,, Jiří Bufka c, Věra Křížková a,b
PMCID: PMC10286520  PMID: 37453902

Abstract

This article compares two important pathophysiological states, Kawasaki disease, and multisystem inflammatory syndrome, in children associated with COVID-19 (MIS-C). Both occur predominantly in children, have a temporal association with an infectious agent, and are associated with immune-system alteration and systemic inflammation under certain circumstances. The two share common pathophysiology, including enhancement of interleukin-1 neutrophils, activation of the inflammasome, pyroptosis, or NETosis. Moreover, the clinical presentation of the diseases overlaps. However, they are indeed two separate diseases, proven by the differences in the epidemiological and etiological aspects and the pathophysiological processes involved in the development and frequency of some clinical signs. This article highlights potentially exciting areas that have not yet been studied in detail, which could help better understand the development of these diseases.

Keywords: COVID-19, Kawasaki disease, MIS-C


Articles from Pediatrics and Neonatology are provided here courtesy of Elsevier

RESOURCES